Home
/
Treatment
/
N-(2-amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide dihydrobromide

N-(2-amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide dihydrobromide

	N-(2-amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide dihydrobromide
Trade Name
Orphan Indication	Hodgkin’s disease
USA Market Approval	USA
USA Designation Date	2007-08-08 00:00:00
Sponsor	Mirati Therapeutics, Inc.;9363 Towne Centre Drive, Suite 200;San Diego, California, 92121

Related Access Program

AbbVie – Non-Hodgkin’s Lymphoma Seattle Genetics, Inc. – Lymphoma, Non-Hodgkin Molecular Templates, Inc. – Non-Hodgkin’s B-cell Lymphoma